tiprankstipranks
Sonoma Pharmaceuticals (SNOA)
NASDAQ:SNOA

Sonoma Pharmaceuticals (SNOA) Technical Analysis

204 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Sonoma Pharmaceuticals’s (SNOA) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Sonoma Pharmaceuticals is a Sell.
Sonoma Pharmaceuticals’s (SNOA) 20-Day exponential moving average is 0.15, while Sonoma Pharmaceuticals’s (SNOA) share price is $0.166, making it a Buy.
Sonoma Pharmaceuticals’s (SNOA) 50-Day exponential moving average is 0.16, while Sonoma Pharmaceuticals’s (SNOA) share price is $0.166, making it a Buy.

Sonoma Pharmaceuticals (SNOA) Pivot Points

Apr 28, 2024, 09:53 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.12
0.14
0.15
0.16
0.17
0.19
0.20
Fibonacci
0.14
0.15
0.15
0.16
0.17
0.18
0.19
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Sonoma Pharmaceuticals (SNOA) Moving Averages

Apr 28, 2024, 09:53 AM
Period
Simple
Exponential
MA5
0.15Buy
0.16Buy
MA10
0.15Buy
0.15Buy
MA20
0.15Buy
0.15Buy
MA50
0.15Buy
0.16Buy
MA100
0.17Buy
0.25Sell
MA200
0.53Sell
0.51Sell
Sonoma Pharmaceuticals’s (SNOA) 10-Day exponential moving average is 0.15, while Sonoma Pharmaceuticals’s (SNOA) share price is $0.166, making it a Buy.
Sonoma Pharmaceuticals’s (SNOA) 100-Day exponential moving average is 0.25, while Sonoma Pharmaceuticals’s (SNOA) share price is $0.166, making it a Sell.
Sonoma Pharmaceuticals’s (SNOA) stock price is $0.166 and Sonoma Pharmaceuticals’s (SNOA) 50-day simple moving average is 0.15, creating a Buy signal.
Sonoma Pharmaceuticals’s (SNOA) stock price is $0.166 and Sonoma Pharmaceuticals’s (SNOA) 100-day simple moving average is 0.17, creating a Buy signal.
Sonoma Pharmaceuticals’s (SNOA) stock price is $0.166 and Sonoma Pharmaceuticals’s (SNOA) 200-day simple moving average is 0.53, creating a Sell signal.

Sonoma Pharmaceuticals (SNOA) Technical Indicators

Apr 28, 2024, 09:53 AM
Name
Value
Implied Action
RSI (14)
62.97
Neutral
STOCH (9,6)
68.59
Neutral
STOCHRSI (14)
68.59
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
35.08
Neutral
Williams %R
-35.00
Buy
CCI (14)
193.13
Sell
ATR (14)
0.02
-
Ultimate Oscillator
47.48
Neutral
ROC
13.33
Buy
Sonoma Pharmaceuticals’s (SNOA) Relative Strength Index (RSI) is 62.97, creating a Neutral signal.
Sonoma Pharmaceuticals’s (SNOA) Trend Strength Indicator (ADX) is 35.08, creating a Neutral signal.
Sonoma Pharmaceuticals’s (SNOA) Commodity Channel Index (CCI) is 193.13, creating a Sell signal.
Sonoma Pharmaceuticals’s (SNOA) Price Rate of Change (ROC) is 13.33, creating a Buy signal.

FAQ

Is SNOA a Buy, Hold, or Sell?
Based on SNOA’s technical indicators, SNOA is a Buy.
    What is SNOA’s RSI (14)?
    SNOA’s RSI (14) is 62.97, which suggests SNOA is a Neutral.
      What is SNOA’s MACD?
      SNOA’s MACD is >-0.01, which suggests SNOA is a Sell.
        What is SNOA’s 5-day moving average?
        SNOA’s 5-day moving average is 0.15, which suggests SNOA is a Buy.
          What is SNOA’s 20-day moving average?
          SNOA 20-day moving average is 0.15, which suggests SNOA is a Buy.
            What is SNOA’s 50-day moving average?
            SNOA’s 50-day moving average is 0.15, which suggests SNOA is a Buy.
              What is SNOA’s 200-day moving average?
              SNOA’s 200-day moving average is 0.53, which suggests SNOA is a Sell.
                What is SNOA’s Williams % R (14)?
                SNOA’s Williams % R (14) is -35.00, which suggests SNOA is a Buy.
                  What is SNOA’s CCI (14)?
                  SNOA’s CCI (14) is 193.13, which suggests SNOA is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis